ASX – Macquarie rates the stock as Outperform
The Outperform rating and $94 target price are maintained.
Read MoreBroker News
ALX – Morgans rates the stock as Hold
The broker retains its Hold rating and notes the potential for a takeover price to exceed the current share price. Separately, the analyst raises its stand-alone valuation for the company to $6.47/share from $6.41.
Read MoreSCG – Macquarie rates the stock as Neutral
The broker observes retail is relatively more defensive as an asset class in cyclical downturns and as a result upgrades to Neutral from Underperform. Target is reduced to $2.79 from $2.85.
Read MoreALX – Credit Suisse rates the stock as Outperform
Credit Suisse raises its target price for Atlas Arteria to $8.60 from $7.10 after media reports that IFM Investors is seeking to increase its shareholding to 15% from 7.94% at an $8.10 offer price.
Read MoreLTR – Macquarie rates the stock as Outperform
The Outperform rating and $2.50 target are retained.
Read MoreDMP – Credit Suisse rates the stock as Neutral
Neutral maintained. Target is reduced to $71.66 from $87.80.
Read MoreAKE – Morgans rates the stock as Add
The target price slips to $16.38 from $16.98, while the add rating is maintained.
Read MoreTWE – UBS rates the stock as Buy
Buy rating and $13.50 target price retained.
Read MoreSHL – Credit Suisse rates the stock as Outperform
The broker reduces the target to $39 from $40 and retains an Outperform rating.
Read MoreASX – Credit Suisse rates the stock as Neutral
Neutral rating maintained. Target is reduced to $85 from $86.
Read MoreHLS – Morgans rates the stock as Add
The target price falls to $4.30 from $5.15 and the Add rating is maintained.
Read MoreCIP – Macquarie rates the stock as Outperform
The broker sticks with Outperform, while an increase in the assumed risk-free rate cuts the target to $3.94 from $4.27.
Read MoreIEL – UBS rates the stock as Buy
Despite the shares looking “expensive” at face value (high PE multiple), UBS sees an attractive entry point, also reflected in its Buy rating. Target $34.60 (was $35.90).
Read MoreTLC – Morgans rates the stock as Add
Morgans initiates coverage on ‘one of the highest performing lotteries businesses in the world’ the Lottery Corp with an Add rating and $5.40 target price.
Read MoreWOR – UBS rates the stock as Buy
Buy rating retained, UBS pegging Worley as an energy transition winner offering a 10-year EPS compound annual growth rate of 10%. Target price rises to $16.40 from $14.40.
Read MoreORG – Morgans rates the stock as Hold
The Hold rating is retained, while the target price falls by -8% to $6.17.
Read MoreAMA – UBS rates the stock as Neutral
The Neutral rating is retained and the target price decreases to $0.23 from $0.29.
Read MoreWGN – Macquarie rates the stock as Outperform
Outperform rating retained. Target price rises to $1.85 from $1.75.
Read MoreSEK – Macquarie rates the stock as Underperform
The broker downgrades to Underperform from Neutral. Target price falls to $19 from $32.
Read MoreWES – UBS rates the stock as Buy
The Buy rating and target price of $56.00 are retained.
Read MoreEDV – Morgans rates the stock as Hold
Target price shifts to $7.30. Hold rating retained.
Read MoreSSR – UBS rates the stock as Buy
UBS has returned – “initiation” – with a Buy rating and $30.50 price target.
Read MoreIFM – UBS rates the stock as Buy
Target price steady at $2.15. Buy rating retained.
Read MoreEDV – Credit Suisse rates the stock as Underperform
The Underperform rating and target price of $6.60 are retained.
Read MoreSTX – Credit Suisse rates the stock as Outperform
The Outperform rating is retained and the target price increases to $0.34 from $0.27.
Read MoreAPE – Morgans rates the stock as Add
The target price, lowered to $14.40 from $16.70, is still well in advance of the current share price and the Add rating is retained.
Read MoreMVF – Macquarie rates the stock as Outperform
The Outperform rating and target price of $1.20 are retained.
Read MoreNHC – Credit Suisse rates the stock as Outperform
Credit Suisse retains its Outperform rating and $4.90 target.
Read MoreSUN – UBS rates the stock as Buy
Among the domestic insurers, the broker continues to prefer Buy-rated Suncorp Group over Insurance Australia Group ((IAG)). The $14.40 target price is retained for the former.
Read MoreS32 – Citi rates the stock as Buy
Citi retains a Buy rating and $5.50 target price.
Read MoreSLC – Morgans rates the stock as Add
The Add rating and $1.37 target price are retained.
Read MoreFPH – Citi rates the stock as Buy
Buy rating retained. Target price falls to NZ$24 from NZ$25.75.
Read MoreALQ – Macquarie rates the stock as Outperform
The Outperform rating is retained and the target price decreases to $14.50 from $14.70.
Read MoreNAN – Morgans rates the stock as Add
The broker maintains its Add rating and $5.43 target price.
Read MorePRN – Macquarie rates the stock as Outperform
The Outperform rating is retained and the target price decreases to $1.00 from $1.10.
Read MoreCGF – Morgans rates the stock as Add
Morgans maintains its Add rating and raises its target price to $8.21 from $8.14.
Read MoreIDX -Macquarie rates the stock as Neutral
Downgrade to Neutral from Outperform, target falls to $4.15 from $4.30.
Read MoreIPL – Morgans rates the stock as Add
The Add rating is retained, while the target falls to $4.45 from $4.56.
Read MoreBWX – Macquarie rates the stock as Outperform
The Outperform rating is retained and the target price decreases to $2.20 from $2.40.
Read MoreWPL – UBS rates the stock as Neutral
UBS maintains a Neutral rating. Target price eases to $31.80 from $32.20
Read More
